# Outcome of Extremely Preterm Infants Who Received Systemic Postnatal Corticosteroid for Bronchopulmonary Dysplasia

> **NCT05055193** · — · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 400 (actual)

## Conditions studied

- Bronchopulmonary Dysplasia

## Interventions

- **DRUG:** Evaluation at 24 months corrected age: respiratory outcome, Neurodevelopmental outcome, Growth outcome

## Key facts

- **NCT ID:** NCT05055193
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01-01
- **Primary completion:** 2013-01-01
- **Final completion:** 2018-12-31
- **Target enrollment:** 400 (ACTUAL)
- **Last updated:** 2021-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05055193

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05055193, "Outcome of Extremely Preterm Infants Who Received Systemic Postnatal Corticosteroid for Bronchopulmonary Dysplasia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05055193. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*